Breaking News Instant updates and real-time market news.

APTV

Aptiv

$84.06

0.17 (0.20%)

08:38
10/02/18
10/02
08:38
10/02/18
08:38

Aptiv initiated with an Outperform at Wolfe Research

Wolfe Research initiated Aptiv with an Outperform and $110 price target.

APTV Aptiv
$84.06

0.17 (0.20%)

05/03/18
DBAB
05/03/18
UPGRADE
Target $110
DBAB
Buy
Aptiv upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Rod Lache upgraded Aptiv to Buy and raised his price target for the shares to $110 from $108. The analyst revisited his growth assumptions following yesterday's Q1 results. He believes Aptiv posted strong organic growth in Q1.
06/05/18
WELS
06/05/18
NO CHANGE
Target $118
WELS
Outperform
Aptiv price target raised to $118 from $105 at Wells Fargo
Wells Fargo analyst David Lim raised his price target for Aptiv to $118 from $105 as he believes it is one of the best plays in the auto supplier realm. The analyst thinks it will not be easy for new competition to match Aptiv's technology. Further, the strong book of business points to potential EPS and revenue upside relative to the 2022 outlook, he contends. Lim reiterates an Outperform rating on the shares.
06/22/18
RBCM
06/22/18
NO CHANGE
Target $115
RBCM
Outperform
Aptiv price target raised to $115 from $110 at RBC Capital
RBC Capital analyst Joseph Spak raised his price target on Aptiv to $115 and kept his Outperform rating, saying his latest meetings with the company's VP and Director of Investor Relations were "highly" encouraging regarding its business trajectory. Spak says the discussion revolved around the company's diversification strategy to reach up to 25% of revenues to be non-automotive by 2025, noting the adjacent CV market as well as opportunities in aero, military, oil & gas, and diversified industrials. The analyst also raised his FY18 EPS target to $5.43 from $5.38.
10/01/18
BARD
10/01/18
DOWNGRADE
BARD
Neutral
Autoliv, TE Connectivity, Methode Electronics downgraded to Neutral at Baird
Baird analyst David Leiker downgraded Autoliv (ALV), Methode Electronics (MEI) and TE Connectivity (TEL) to Neutral from Outperform and lowered his respective price targets to $90 from $120, $39 from $47 and $93 from $105, telling investors in a research note that risk/reward is seen in balance. In a research note on the global automotive sector to investors, Leiker says that while the magnitude of BMW's (BMWYY) recent update equals other adjustments already made, stocks are reacting poorly and current downtrend suggests valuation disconnect will likely persist until greater clarify on 2019 is offered. Top names remain Aptiv (APTV), Lear (LEA) and Visteon (VC), while BorgWarner (BWA), Delphi (DLPH) and Littelfuse (LFUS) remain Outperform-rated.

TODAY'S FREE FLY STORIES

SMH

Market Vectors Semiconductor

$95.61

(0.00%)

09:42
10/23/18
10/23
09:42
10/23/18
09:42
Technical Analysis
Technical Take: Market Vectors Semiconductor at new 52-week low, major top »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$204.52

(0.00%)

09:40
10/23/18
10/23
09:40
10/23/18
09:40
Options
Unusually active option classes on open October 23rd »

Unusual total active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HON

Honeywell

$152.63

-0.86 (-0.56%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
Honeywell rating change  »

Honeywell upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

$40.40

-0.59 (-1.44%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
QTS Realty Trust rating change  »

QTS Realty Trust upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$261.03

0.97 (0.37%)

09:38
10/23/18
10/23
09:38
10/23/18
09:38
Periodicals
Breaking Periodicals news story on Tesla »

Citron says long Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

KOF

Coca-Cola Femsa

$59.41

-1.75 (-2.86%)

09:36
10/23/18
10/23
09:36
10/23/18
09:36
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.93

0.34 (0.71%)

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Oracle initiated  »

Oracle initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Conference/Events
JPMorgan European & EMEA analysts to hold analyst/industry conference call »

European Utilities…

ABBV

AbbVie

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
AbbVie initiated  »

AbbVie initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SNY

Sanofi

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Sanofi initiated  »

Sanofi reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

RHHBY

Roche

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Roche initiated  »

Roche reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 24

    Dec

09:35
10/23/18
10/23
09:35
10/23/18
09:35
General news
Treasury 2-year auction outlook: the $38 B 2-year sale »

Treasury 2-year auction…

PFE

Pfizer

$44.37

-0.13 (-0.29%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Pfizer initiated  »

Pfizer reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

GSK

GlaxoSmithKline

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
GlaxoSmithKline initiated  »

GlaxoSmithKline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 07

    Nov

LLY

Eli Lilly

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Eli Lilly initiated  »

Eli Lilly reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

NVS

Novartis

$87.12

-0.07 (-0.08%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Novartis initiated  »

Novartis reinitiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MRK

Merck

$72.56

0.22 (0.30%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Merck initiated  »

Merck reinitiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

BMY

Bristol-Myers

$50.87

-3.44 (-6.33%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Bristol-Myers initiated  »

Bristol-Myers reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 20

    May

AZN

AstraZeneca

$39.50

0.295 (0.75%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
AstraZeneca initiated  »

AstraZeneca reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

MLCO

Melco Resorts & Entertainment

$17.74

-0.04 (-0.22%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Downgrade
Melco Resorts & Entertainment rating change  »

Melco Resorts &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.10

-0.56 (-2.10%)

, BAC

Bank of America

$27.36

-0.95 (-3.36%)

09:33
10/23/18
10/23
09:33
10/23/18
09:33
Technical Analysis
Technical Take: Bank of America drops in early trading »

The shares were last down…

XLF

Financial Select Sector

$26.10

-0.56 (-2.10%)

BAC

Bank of America

$27.36

-0.95 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

UTX

United Technologies

$126.42

-2.22 (-1.73%)

09:33
10/23/18
10/23
09:33
10/23/18
09:33
Hot Stocks
United Technologies says geo-political outlook is the biggest concern »

Says tariffs present a 5c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UBS

UBS

$13.77

-0.085 (-0.61%)

09:32
10/23/18
10/23
09:32
10/23/18
09:32
Periodicals
UBS backs down warning to staff about traveling to China, FT reports »

UBS has rescinded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:31
10/23/18
10/23
09:31
10/23/18
09:31
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.